Clinical Trials Directory

Trials / Sponsors / Guangzhou Gloria Biosciences Co., Ltd.

Guangzhou Gloria Biosciences Co., Ltd.

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingMobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Multiple Myeloma
Phase 32025-12-01
UnknownSafety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Phase 1 / Phase 22023-08-10
Not Yet RecruitingA Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, R
Persistent, Recurrent, or Metastatic Cervical Cancer
Phase 32023-05-01
RecruitingImmuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Solid Tumor
Phase 1 / Phase 22022-10-31
UnknownGLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (
Classic Hodgkin's Lymphoma, Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Phase 32022-09-01
UnknownStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 22019-05-15
UnknownStudy of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma
Classical Hodgkin's Lymphoma
Phase 22018-08-24
CompletedStudy of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12017-07-01